Principal component analysis of the same 342 proteins further supported the stratification of individuals into the three diagnostic groups, showing a separation between Aβ+/tau+, Aβ+/tau−, and non-AD cases (Fig. 5B). Here, MAPT is linked to Alzheimer disease.